Crizotinib for ALK-Rearranged Non-Small Cell Lung Cancer: A New Targeted Therapy for a New Target

Title
Crizotinib for ALK-Rearranged Non-Small Cell Lung Cancer: A New Targeted Therapy for a New Target
Authors
Keywords
-
Journal
CLINICAL CANCER RESEARCH
Volume 18, Issue 14, Pages 3737-3742
Publisher
American Association for Cancer Research (AACR)
Online
2012-05-01
DOI
10.1158/1078-0432.ccr-11-2393

Ask authors/readers for more resources

Discover Peeref hubs

Discuss science. Find collaborators. Network.

Join a conversation

Become a Peeref-certified reviewer

The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.

Get Started